How Flea and Tick Medicine Actually Works on Dogs

Flea and tick medicines for dogs work by delivering a chemical that is toxic to parasites but, in most cases, far less harmful to mammals. The specific mechanism depends on the type of product: oral chewables circulate an insecticide through your dog’s bloodstream so that any flea or tick that bites gets a lethal dose, while topical treatments and collars spread active ingredients across the skin and coat, killing or repelling parasites on contact. The differences between these approaches matter more than most dog owners realize, affecting everything from how fast ticks die to whether the medicine can prevent disease transmission.

Oral Chewables and the Isoxazoline Class

The most widely prescribed flea and tick products today are oral chewable tablets containing drugs from a class called isoxazolines. Brand names you have probably heard of, like Bravecto, NexGard, Simparica, and Credelio, all belong to this group. When your dog swallows one of these tablets, the active ingredient is absorbed through the digestive tract, enters the bloodstream, and distributes throughout the body’s tissues, including the skin. The drug then sits in your dog’s system for weeks, waiting for a parasite to feed.

The killing mechanism targets a specific part of the insect nervous system. Isoxazolines block chloride channels that are gated by a neurotransmitter called GABA, along with a second type gated by glutamate. When a flea bites or a tick begins feeding, it ingests blood containing the drug. The drug locks open these chloride channels in the parasite’s nerve cells, causing uncontrolled nerve firing, paralysis, and death. Research on fluralaner, the active ingredient in Bravecto, showed that its primary target is the GABA-gated chloride channel, with tick receptors being roughly 50 times more sensitive to the drug than the secondary glutamate channel target.¹

The critical point for dog owners is that these drugs require the parasite to bite first. An isoxazoline does not repel fleas or ticks. A tick can still land on your dog, crawl through the fur, and attach. But once it starts feeding, it ingests the drug and typically dies within hours. That speed turns out to be the whole ballgame when it comes to preventing tick-borne disease.

How Topical Products and Collars Differ

Topical spot-on treatments work on a fundamentally different principle. When you squeeze a pipette of product onto the skin between your dog’s shoulder blades, the active ingredients dissolve into the natural oils of the skin and coat, then spread across the body over the next day or two. Instead of circulating in the blood, these chemicals sit in the lipid layer of the skin and hair follicles. Parasites are exposed to the drug through direct contact with the treated coat, meaning they can be killed or even repelled before they bite.

Common active ingredients in topicals include fipronil (which also targets GABA channels in insects, but through a different binding site than isoxazolines), imidacloprid (a neonicotinoid that disrupts a different nerve receptor), and permethrin (a synthetic pyrethroid that interferes with sodium channels in the insect nervous system). Each of these attacks a different piece of the parasite’s electrical wiring, but the end result is the same: uncontrolled nerve activity, paralysis, and death.

Flea and tick collars work on a similar surface-distribution model but deliver their ingredients continuously over months. The collar matrix slowly releases active chemicals that migrate across the skin. A widely studied combination collar uses imidacloprid and flumethrin together, and research has shown that these two compounds act synergistically, meaning their combined effect is greater than you would expect from adding each one’s individual contribution. This synergy, delivered through a slow-release polymer system, provides protection for about eight months.² Field studies in heavily infested dog populations confirmed that these collars could both cure existing infestations and prevent new ones over that full duration.³

Why Speed of Kill Matters for Disease

Many dog owners think flea and tick prevention is just about comfort, about keeping their dog from scratching. But the bigger concern is disease. Ticks transmit pathogens like the bacteria that cause Lyme disease, and fleas can carry tapeworm larvae and other organisms. Whether your dog’s medicine can prevent disease transmission depends on how fast it kills the parasite after attachment.

Tick-borne pathogens do not transfer to the host instantly. The bacteria that cause Lyme disease, for example, live in the tick’s gut and need time to migrate to the salivary glands before they can enter the dog. This process is broadly understood to require somewhere between 24 and 48 hours of attachment. For other pathogens like the agent behind anaplasmosis, the window may be shorter, around 16 to 24 hours.⁴ The risk of transmission increases the longer a tick stays attached and feeding, with the danger rising sharply after about 48 hours.

This creates a race: can the drug kill the tick before the pathogen makes it from gut to salivary gland to your dog’s bloodstream? Studies with isoxazolines have demonstrated that their speed of kill is fast enough to prevent Lyme disease transmission. Research on lotilaner, the active ingredient in Credelio, confirmed that its rapid action against blacklegged ticks prevented the bacteria from establishing infection in dogs.⁵ A separate study using a topical product containing a different combination found that killing ticks fast enough to prevent attachment and engorgement also prevented the acquisition of the Lyme disease bacterium.⁶

The honest gap in the science is that most of this research focuses on Lyme disease. Pathogens that transmit faster, like the one behind anaplasmosis, are harder to outrun, and researchers have acknowledged that more study is needed on whether rapid-kill acaricides are equally effective against those quicker-transmitting organisms.

Breaking the Flea Life Cycle with Growth Regulators

Killing adult fleas on your dog is only half the battle. A single female flea can lay dozens of eggs per day, and those eggs roll off your dog into carpets, bedding, and yard soil. The larvae that hatch live in the environment, not on your pet, feeding on organic debris for a week or two before pupating. The pupal cocoon can survive for months, waiting for vibrations or warmth that signal a host is nearby. This means your home can harbor a massive reservoir of future fleas even when your dog is being treated.

Insect growth regulators are chemicals designed to interrupt this cycle. They mimic juvenile hormones that insects use to control their own development, throwing the process into disarray. Pyriproxyfen, a common growth regulator found in some topical flea products and environmental sprays, has a dramatic effect on flea eggs. Eggs laid by treated fleas within the first 70 hours after exposure were often devoid of yolk and collapsed after being laid. Eggs laid later contained minimal yolk and never developed a viable embryo.⁷ Methoprene, another widely used growth regulator, works differently: eggs exposed to it remain outwardly normal and turgid, but the embryos inside die during development or the larvae die within hours of hatching.

A related compound, fenoxycarb, showed embryo-killing activity that was not limited to any particular developmental stage. Even brief exposure of just 60 seconds produced lethal disruption of embryonic development, and it also killed newly hatched larvae by destroying their gut tissue.⁸ Growth regulators do not kill adult fleas, so they are typically combined with an adulticide in the same product or used alongside one. Their value is in shutting down the next generation, which is how you actually end an infestation rather than just treading water.

Why Some Breeds Are at Higher Risk

Not every dog processes these drugs the same way, and certain breeds face a real danger from specific types of flea and tick medications. The issue centers on a gene called MDR1, which produces a protein that acts as a gatekeeper at the blood-brain barrier. This protein actively pumps certain drugs back out of the brain, keeping them from reaching concentrations that would be toxic to the central nervous system. In mammals, the GABA receptors that isoxazolines and other parasiticides target exist in the brain. The reason these drugs are safe for most dogs is that the blood-brain barrier keeps the drug concentrations in the brain too low to cause problems.

A deletion mutation in the MDR1 gene, found in Collies, Australian Shepherds, and a number of related herding breeds and their mixes, results in a nonfunctional version of this pump protein.⁹ Dogs with two copies of the mutant gene are especially vulnerable. Without a working pump, drugs that would normally be excluded from the brain can accumulate there at dangerous levels. This is particularly well documented with macrocyclic lactones like ivermectin, a class of drugs used in some heartworm preventives and older parasite treatments.¹⁰ The result can be severe neurological toxicity, including tremors, disorientation, blindness, and in extreme cases, coma or death.

Genetic testing for the MDR1 mutation is widely available and inexpensive. If you own a Collie, Australian Shepherd, Shetland Sheepdog, or a mix of these breeds, getting the test done before starting any parasite prevention program is a sensible precaution. Your vet can then choose a product and dose that avoids the drugs most likely to cause problems in MDR1-mutant dogs. The mutation has also been identified in cats, though that is less commonly discussed.¹¹

Side Effects and the Isoxazoline Safety Debate

The isoxazoline class has been one of the most commercially successful drug classes in veterinary medicine, but it has also attracted scrutiny over adverse effects. The FDA added a warning to all isoxazoline products in 2018, noting potential neurological events including muscle tremors, seizures, and loss of coordination. A survey analyzing adverse event reports found that muscle tremors and convulsions were the most commonly reported neurological signs in dogs, occurring even at labeled therapeutic doses.¹²

A more detailed analysis of FDA and European Medicines Agency adverse event databases found that the rates of reported neurological events varied between specific isoxazoline drugs. Seizures, trembling, and coordination problems ranged from roughly 3 to 8 percent of adverse event reports for some compounds, while one compound showed markedly higher rates of these neurological signs in its reporting data.¹³ That same analysis noted that European adverse event reports showed death rates roughly seven to ten times higher than those in the corresponding FDA reports, suggesting potential differences in reporting practices rather than necessarily different drug safety profiles.

Context matters here. Adverse event reports are voluntary, and they capture reports where someone suspected a connection between the drug and the symptom, not cases where a connection was proven. The vast majority of dogs take isoxazolines without any noticeable problems. But if your dog has a history of seizures or a neurological condition, most vets will steer you toward a different class of product. The evidence is strong enough that caution is warranted in those specific dogs, even if the absolute risk for a healthy dog appears low.

Practical Details That Affect How Well the Medicine Works

One surprisingly impactful factor for oral chewables is whether your dog eats with the tablet. A pharmacokinetics study of fluralaner found that giving the chewable with food increased the amount of drug absorbed into the bloodstream by about two and a half times compared to giving it on an empty stomach.¹⁴ The peak blood concentration also roughly doubled. This is why the label instructions for most oral flea and tick chewables tell you to give them with a meal or shortly after feeding. Skipping this step does not just reduce efficacy slightly; it can cut absorption in half, potentially leaving gaps in protection toward the end of the dosing period.

For topical spot-on products, the main concern is water. Dog owners often worry that swimming or bathing will wash off the treatment. A study on topical fluralaner tested exactly this, subjecting treated dogs to water immersion and shampooing. Efficacy against both ticks and fleas remained between 99 and 100 percent throughout the 12-week treatment period regardless of water exposure.¹⁵ The reason is that the drug binds to skin oils and hair follicles rather than just sitting on the surface, so casual water contact does not strip it away. That said, most product labels still recommend waiting at least 24 to 48 hours after application before bathing, to give the product time to fully distribute across the skin.

Why You Should Never Use Dog Products on Cats

Permethrin, one of the most effective and widely used ingredients in dog flea and tick products, is extremely toxic to cats. Cats lack the liver enzyme needed to break down permethrin efficiently, so even small amounts can cause fatal poisoning. Documented cases of feline permethrin intoxication have resulted from owners applying canine spot-on products directly to their cats.¹⁶ Symptoms include severe tremors, seizures, and death without emergency treatment. Even indirect exposure matters: cats that groom or sleep next to a recently treated dog can absorb enough permethrin through their skin or mouth to become sick. If you have both dogs and cats in your household, this is one of the most important safety considerations when choosing a flea and tick product.

The Resistance Question

Given how many parasiticides have been used over the decades, you might wonder whether fleas and ticks are becoming resistant. Historically, resistance has developed to older classes of insecticides used in environmental flea control, including carbamates, organophosphates, and pyrethroids. However, for the newer generation of products used directly on pets, confirmed resistance has not yet been demonstrated. Product failures that dog owners report have more often been traced to operational factors, like not treating all the pets in the household, failing to follow label directions, or not addressing the environmental flea reservoir in the home.¹⁷

That does not mean resistance will never emerge. Parasites evolve under selection pressure, and any chemical used widely enough for long enough will eventually face resistant populations. But for now, if your dog’s flea and tick medicine seems to not be working, the more likely explanation is a gap in application, dosing, or environmental management rather than a genetically resistant superbug.

Environmental Runoff from Treated Pets

A dimension of flea and tick treatment that rarely comes up at the vet’s office is what happens to these chemicals after they leave your dog. Topical treatments in particular do not stay on your pet indefinitely. They wash off during baths, get transferred to bedding, and enter waterways when treated dogs swim. A UK study found that fipronil and imidacloprid, two of the most common spot-on ingredients, were detected in 100 percent of washoff samples from treated dogs. Bathing accounted for the largest emissions per event, with up to about 17 percent of applied imidacloprid and roughly 25 percent of applied fipronil washing off in a single bath. When researchers modeled the cumulative effect across all routes, owner handwashing after petting turned out to be the largest overall source of down-the-drain emissions, with measurable chemical runoff continuing for at least 28 days after a single product application.¹⁸

These chemicals have been widely detected in UK surface waters at concentrations shown to harm aquatic invertebrates. A separate survey estimated that spot-on treated dogs in the UK swim, get bathed, and have their bedding washed millions of times per year, creating a continuous pathway of insecticide into the water system.¹⁹ Current regulations for veterinary medicines used on companion animals assume that environmental exposure from these products is low and do not require assessment of down-the-drain pathways, a gap that researchers have argued needs to be addressed.

This does not mean you should stop treating your dog. Flea and tick prevention protects against real diseases. But it is worth knowing that the environmental footprint of these products is not zero, and it is one reason some veterinarians suggest using oral treatments rather than topicals when the clinical situation allows, since oral drugs are metabolized internally and far less of the active ingredient enters waterways through routine activities like bathing or petting.